1. Home
  2. XOS vs NEPH Comparison

XOS vs NEPH Comparison

Compare XOS & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xos Inc.

XOS

Xos Inc.

HOLD

Current Price

$2.79

Market Cap

37.2M

ML Signal

HOLD

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$3.47

Market Cap

40.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XOS
NEPH
Founded
2016
1997
Country
United States
United States
Employees
101
N/A
Industry
Construction/Ag Equipment/Trucks
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.2M
40.1M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
XOS
NEPH
Price
$2.79
$3.47
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$7.00
$6.00
AVG Volume (30 Days)
1.1M
9.3K
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1000.00
EPS
N/A
0.01
Revenue
N/A
$18,789,000.00
Revenue This Year
$29.02
$11.24
Revenue Next Year
N/A
$11.58
P/E Ratio
N/A
$340.00
Revenue Growth
N/A
32.67
52 Week Low
$1.60
$2.66
52 Week High
$8.27
$6.42

Technical Indicators

Market Signals
Indicator
XOS
NEPH
Relative Strength Index (RSI) 45.46 50.62
Support Level $1.94 $2.77
Resistance Level $3.07 $3.79
Average True Range (ATR) 0.35 0.23
MACD -0.13 0.02
Stochastic Oscillator 0.64 46.15

Price Performance

Historical Comparison
XOS
NEPH

About XOS Xos Inc.

Xos Inc is a fleet electrification solutions provider committed to the decarbonization of commercial transportation. Xos designs and manufactures Class 5 through 8 battery-electric commercial vehicles that travel on last-mile, back-to-base routes of up to 200 miles per day. Xos also offers charging infrastructure products and services through Xos Energy Solutions to support electric vehicle fleets. Its products include Stepvan, MDXT, HDXT, Xosphere, and Xos Energy Solutions.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: